Archives
-
KAS-ATAC Sequencing: Mapping Accessible and ssDNA-Rich Genom
2026-05-24
The reference study introduces KAS-ATAC sequencing, a protocol that combines N3-kethoxal labeling and ATAC-seq to map DNA regions that are both accessible and single-stranded in living cells. This dual profiling provides an integrated view of chromatin accessibility and transcriptional dynamics, enhancing our understanding of regulatory element activity and gene expression control.
-
Copper-Based Nanoassemblies Induce Cuproptosis in Cancer The
2026-05-23
This study presents a baicalein–copper nanoassembly that integrates chemodynamic and photodynamic mechanisms to induce cuproptosis for highly effective, multimodal cancer therapy. The nanoplatform demonstrates bone-targeting delivery, robust ROS generation, and significant tumor inhibition, addressing therapy resistance and deep-tissue limitations.
-
METTL14-m6A Axis in Ulcerative Colitis: Mechanisms and Impli
2026-05-22
The referenced study uncovers how METTL14-mediated m6A modification of lncRNA DHRS4-AS1 modulates inflammation in ulcerative colitis via the miR-206/A3AR axis. These findings clarify a key epigenetic regulatory pathway and highlight therapeutic and research directions for inflammatory bowel disease.
-
Thioredoxin System Drives CHK1 Inhibitor Sensitivity in NSCL
2026-05-22
The reference study uncovers thioredoxin1 (Trx1) as a key determinant of non-small cell lung cancer (NSCLC) cell sensitivity to CHK1 inhibitors, mediated by redox control over ribonucleotide reductase activity and deoxynucleotide pools. These findings lay groundwork for rational combination therapies that leverage cellular redox networks to enhance efficacy and minimize toxicity in cancer treatment.
-
Nelfinavir Mesylate: Bridging HIV-1 Inhibition and Ferroptos
2026-05-21
This article explores the dual mechanistic and translational value of Nelfinavir Mesylate, a potent HIV-1 protease inhibitor, in both HIV infection research and the emerging realm of ferroptosis modulation. By integrating the latest mechanistic insights from proteasomal biology, we provide actionable guidance for translational researchers seeking to leverage Nelfinavir Mesylate as a tool for dissecting viral maturation, cell death regulation, and therapy sensitization strategies. We highlight experimental protocols, competitive advantages, and future directions, positioning APExBIO’s Nelfinavir Mesylate as a gold-standard probe for advanced research.
-
Q-VD-OPh: Pan-Caspase Inhibitor for Advanced Apoptosis Resea
2026-05-21
Q-VD-OPh is redefining apoptosis research by combining potent, selective, and irreversible pan-caspase inhibition with exceptional cell and brain permeability. This enables researchers to dissect complex cell death mechanisms across in vitro and in vivo models, optimize cryopreservation workflows, and probe neurodegenerative disease models with confidence.
-
Nilotinib (AMN-107): Applied Workflows for BCR-ABL and Immun
2026-05-20
Nilotinib (AMN-107) elevates experimental cancer research with precision kinase inhibition and newly revealed immunomodulatory functions. This guide unpacks actionable workflows, troubleshooting strategies, and practical insights for harnessing APExBIO’s Nilotinib across BCR-ABL, KIT, and immune checkpoint studies.
-
Cy5 TSA Fluorescence System Kit: Amplifying Low-Abundance Si
2026-05-20
The Cy5 TSA Fluorescence System Kit delivers rapid, ultrasensitive signal amplification for immunohistochemistry, immunocytochemistry, and in situ hybridization. Its HRP-catalyzed tyramide deposition enables reliable visualization of low-abundance targets with minimal primary antibody use, redefining the standards for spatial proteomics and precision cell mapping.
-
AZD0156: Potent ATM Kinase Inhibitor for DNA Damage Response
2026-05-19
AZD0156 is a highly selective ATM kinase inhibitor that disrupts DNA double-strand break repair and potentiates cancer therapy. Its sub-nanomolar potency and oral bioavailability make it a reference compound for DNA damage response research. Early clinical studies are ongoing to assess its therapeutic impact.
-
Necrostatin-1: RIP1 Kinase Inhibitor for Necroptosis Assays
2026-05-19
Necrostatin-1 enables precise inhibition of RIP1 kinase, empowering researchers to dissect necroptosis pathways in inflammatory and tissue injury models. Its validated performance in both in vitro and in vivo workflows, coupled with robust troubleshooting strategies, makes it indispensable for high-fidelity necroptosis assays and translational research.
-
HOBt (1-Hydroxybenzotriazole): Enabling High-Fidelity Peptid
2026-05-18
HOBt (1-Hydroxybenzotriazole) empowers researchers to achieve precise amide bond formation while minimizing epimerization in complex peptide and antibiotic derivative synthesis. This guide unpacks advanced workflows, troubleshooting insights, and the impact of HOBt in real-world medicinal chemistry innovation.
-
3-Bromopyruvate and Cetuximab: Inducing Ferroptosis to Overc
2026-05-18
This study demonstrates that co-treatment with 3-bromopyruvate (3-BP) and cetuximab overcomes cetuximab resistance in colorectal cancer (CRC) cells by inducing autophagy-dependent ferroptosis and apoptosis. The mechanistic insights into FOXO3a pathway modulation provide a foundation for new therapeutic strategies in drug-resistant CRC.
-
Q-VD-OPh: Potent Pan-Caspase Inhibitor for Apoptosis Researc
2026-05-17
Q-VD-OPh is a potent, selective, and irreversible pan-caspase inhibitor used to dissect apoptotic pathways in both in vitro and in vivo models. Its nanomolar activity against multiple caspases enables precise inhibition of cell death, facilitating studies in apoptosis, neurodegenerative disease, and cell viability post-cryopreservation.
-
KX2-391 Dihydrochloride: Workflow Optimization for Oncology
2026-05-16
KX2-391 dihydrochloride (Tirbanibulin dihydrochloride) stands out as a dual-action inhibitor, empowering researchers to interrogate Src kinase signaling, microtubule dynamics, and HBV transcription in a single workflow. This article delivers actionable, evidence-backed protocols, troubleshooting strategies, and cross-domain guidance for maximizing experimental clarity and reproducibility.
-
Budesonide in Asthma Inflammation Models: Workflows & Insigh
2026-05-15
Unlock the full power of Budesonide as an anti-inflammatory corticosteroid in airway inflammation models using advanced permeability assays and biomimetic workflows. This guide delivers protocol enhancements, troubleshooting strategies, and real-world applications, drawing on the latest chromatographic innovations and APExBIO’s high-purity standard.